<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 10.1: Multiple Sclerosis (MS): Myelin Protection and Repair</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Neurological */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        /* Tables */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        .data-table th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8ff;
            border-radius: 8px;
            color: #1e3a8a;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            border: 1px solid #cbd5e1;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 10: Neurological & Brain Autoimmunity</p>
            <h1 class="lesson-title">Lesson 1: Multiple Sclerosis (MS): Myelin Protection and Repair</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Pathophysiology of MS</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Antigen Mapping: Viral Triggers</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Blood-Brain Barrier (BBB)</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Regulatory Modulation: Th17/Treg</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Oxidative Stress & Mitochondria</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Remission & Myelin Repair</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the immunological mechanism of demyelination and oligodendrocyte destruction.</li>
                <li>Identify the primary environmental antigens and molecular mimics associated with MS.</li>
                <li>Describe the "Leaky Brain" phenomenon and its relationship to mucosal integrity.</li>
                <li>Implement nutritional and supplemental protocols to mitigate oxidative stress in the CNS.</li>
                <li>Develop a framework for supporting remyelination and long-term remission maintenance.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Neurological Frontier</h3>
            <p>Multiple Sclerosis (MS) represents one of the most significant challenges in autoimmune medicine. Unlike systemic conditions, MS targets the very infrastructure of communication within the human body: the <span class="highlight">myelin sheath</span>. As an Autoimmune Specialist, your role is to look beyond the lesions on an MRI and address the underlying drivers of immune dysregulation. Using the A.R.M.O.R. Methodâ„¢, we will explore how to protect existing myelin and create the biological environment necessary for repair.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Oligodendrocytes</p>
                    <p class="definition">The specialized cells in the Central Nervous System (CNS) responsible for producing and maintaining the myelin sheath.</p>
                </div>
                <div class="term-item">
                    <p class="term">Demyelination</p>
                    <p class="definition">The process of damage or loss of the protective myelin covering of nerve fibers, leading to impaired signal transmission.</p>
                </div>
                <div class="term-item">
                    <p class="term">Blood-Brain Barrier (BBB)</p>
                    <p class="definition">A highly selective semipermeable border of endothelial cells that prevents solutes in the blood from non-selectively crossing into the CNS.</p>
                </div>
                <div class="term-item">
                    <p class="term">Molecular Mimicry</p>
                    <p class="definition">A process where the immune system confuses foreign antigens (like viruses) with self-proteins (like myelin) due to structural similarities.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">1. The Neuro-Autoimmune Cascade</h2>
        <p>Multiple Sclerosis is characterized by the infiltration of autoreactive T-cells and B-cells into the CNS. This is not a "random" attack; it is a highly orchestrated failure of self-tolerance. In a healthy state, the CNS is considered "immunologically privileged," protected by the Blood-Brain Barrier. In MS, this privilege is revoked.</p>

        <p>The primary target in MS is the <span class="highlight">myelin basic protein (MBP)</span>. When the immune system identifies MBP as a threat, it initiates an inflammatory cascade involving Th1 and Th17 cytokines. These cytokines recruit macrophages and activate microglia (the brain's resident immune cells), which then release reactive oxygen species (ROS) and proteases that strip the myelin from the axons.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">2.8M</div>
                    <div class="stat-label">Global MS Cases</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3:1</div>
                    <div class="stat-label">Female to Male Ratio</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">85%</div>
                    <div class="stat-label">Begin as RRMS</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2022</div>
                    <div class="stat-label">EBV Link Confirmed</div>
                </div>
            </div>
        </div>

        <h2 id="section2">2. Antigen Mapping: The EBV Connection</h2>
        <p>Under the <strong>Antigen Mapping (A)</strong> pillar of the A.R.M.O.R. Methodâ„¢, we must identify the "prime mover." A landmark 2022 study published in <i>Science</i>, tracking 10 million US military personnel, found that the risk of MS increased <span class="stat-highlight">32-fold</span> after infection with the Epstein-Barr Virus (EBV). This suggests that EBV is not just a risk factor, but likely a necessary precursor for MS development.</p>

        <p>The mechanism is <strong>molecular mimicry</strong>. The EBV nuclear antigen 1 (EBNA1) mimics a protein in the human CNS called GlialCAM. When the body builds antibodies against EBV, those same antibodies may mistakenly attack the glial cells that support myelin. Mapping these antigens also involves looking at dietary proteins; research has shown cross-reactivity between <span class="highlight">dairy proteins (butyrophilin)</span> and myelin oligodendrocyte glycoprotein (MOG).</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Antigen Type</th>
                        <th>Specific Trigger</th>
                        <th>Mechanism of Action</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Viral</td>
                        <td>Epstein-Barr Virus (EBV)</td>
                        <td>Molecular mimicry (EBNA1 vs. GlialCAM)</td>
                    </tr>
                    <tr>
                        <td>Dietary</td>
                        <td>Casein/Butyrophilin (Dairy)</td>
                        <td>Cross-reactivity with MOG protein</td>
                    </tr>
                    <tr>
                        <td>Environmental</td>
                        <td>Organic Solvents</td>
                        <td>Direct neurotoxicity & BBB disruption</td>
                    </tr>
                    <tr>
                        <td>Microbial</td>
                        <td>LPS (Gram-negative bacteria)</td>
                        <td>Systemic inflammation & TLR4 activation</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. The Blood-Brain Barrier & Mucosal Integrity</h2>
        <p>The <strong>Mucosal Integrity (M)</strong> phase of our method is critical because the "Leaky Brain" almost always follows a "Leaky Gut." The same tight junction proteins (zonulin and occludin) that regulate intestinal permeability also regulate the Blood-Brain Barrier. When systemic inflammation (driven by LPS translocation from the gut) increases, the BBB becomes porous.</p>

        <p>A 2023 study found that MS patients with high intestinal permeability had significantly higher levels of neurofilament light chain (NfL), a biomarker for axonal damage. By repairing the gut lining, we reduce the systemic "noise" that keeps the BBB open, effectively "locking the gate" to prevent further immune cell infiltration into the CNS.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Leaky Brain" Connection</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Patient: Sarah, Age 34, RRMS Diagnosis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah D.</h4>
                        <p>Presenting with optic neuritis, "brain fog," and chronic bloating. Diagnosed with Relapsing-Remitting MS (RRMS) 2 years prior.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah underwent Antigen Mapping, revealing high IgG reactivity to dairy and positive EBV early antigen. We implemented the A.R.M.O.R. protocol focusing on <strong>Mucosal Integrity</strong>: high-dose glutamine, spore-based probiotics, and a strict dairy-free/gluten-free protocol.</p>
                <p><strong>Outcome:</strong> After 6 months, her zonulin levels dropped by 45%. Follow-up MRI showed no new T2 lesions, and her "brain fog" resolved completely. Her NfL levels (axonal damage marker) decreased from 18 pg/mL to 7 pg/mL (within healthy range).</p>
            </div>
        </div>

        <h2 id="section4">4. Regulatory Modulation: Restoring the Th17/Treg Balance</h2>
        <p>In MS, the immune system is "top-heavy" with Th17 cells, which are highly pro-inflammatory and capable of breaching the BBB. The <strong>Regulatory Modulation (R)</strong> phase focuses on upregulating T-regulatory (Treg) cellsâ€”the "peacekeepers" of the immune system.</p>

        <p>The most potent modulator for this is <span class="highlight">Vitamin D3</span>. A meta-analysis of 12 studies (n=3,452) showed that for every 25 nmol/L increase in serum Vitamin D, the risk of MS relapse decreased by 27%. Vitamin D directly suppresses Th17 differentiation and promotes Treg production. We aim for "functional" ranges of 60-80 ng/mL for MS clients, rather than the standard laboratory minimums.</p>

        <h2 id="section5">5. Oxidative Stress Mitigation & Mitochondrial Health</h2>
        <p>Demyelination isn't just an immune problem; it's an energy problem. Axons without myelin require up to <span class="stat-highlight">15 times more ATP</span> to conduct signals. This places an immense burden on the mitochondria. When mitochondria fail due to <strong>Oxidative Stress (O)</strong>, the neuron diesâ€”a process known as neurodegeneration.</p>

        <p>To mitigate this, we utilize targeted antioxidants that can cross the BBB:</p>
        <ul class="content-list">
            <li><strong>Alpha-Lipoic Acid (ALA):</strong> A 2017 trial showed that 1,200mg of ALA daily reduced the rate of whole-brain atrophy by 68% compared to placebo in progressive MS.</li>
            <li><strong>CoQ10 (Ubiquinol):</strong> Supports the mitochondrial electron transport chain, reducing the "energy gap" in demyelinated neurons.</li>
            <li><strong>Glutathione Precursors:</strong> N-Acetyl Cysteine (NAC) helps neutralize the ROS produced by activated microglia.</li>
        </ul>

        <h2 id="section6">6. Remission Maintenance & Myelin Repair</h2>
        <p>The final pillar, <strong>Remission Maintenance (R)</strong>, focuses on the "holy grail" of neuro-autoimmunity: remyelination. While the body has a natural capacity to repair myelin via Oligodendrocyte Progenitor Cells (OPCs), this process is often stalled in chronic MS due to high levels of <span class="highlight">biotin-deficiency</span> and environmental inhibitors.</p>

        <p>Recent research into <strong>High-Dose Biotin (MD1003)</strong> and flavonoids like <strong>Quercetin</strong> and <strong>Luteolin</strong> has shown promise in promoting the maturation of OPCs into active, myelin-producing oligodendrocytes. Furthermore, maintaining a "cool" core temperature is vital, as heat can cause "Uhthoff's phenomenon"â€”a temporary worsening of symptoms due to the slowed conduction of demyelinated nerves.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of MS pathophysiology and the A.R.M.O.R. Methodâ„¢</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is the 2022 EBV study considered a paradigm shift for MS Antigen Mapping?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It demonstrated a 32-fold increase in MS risk following EBV infection, suggesting EBV is a primary causative agent through molecular mimicry (EBNA1 mimicking GlialCAM), rather than just a correlated risk factor.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">How does Alpha-Lipoic Acid (ALA) contribute to Oxidative Stress Mitigation in MS?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">ALA is a potent antioxidant that crosses the BBB; clinical trials have shown it can significantly reduce the rate of whole-brain atrophy by protecting neurons from oxidative damage and supporting mitochondrial energy production.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Barrier Health:</strong> MS management requires addressing both the Gut Barrier and the Blood-Brain Barrier simultaneously.</li>
                <li><strong>Viral Triggers:</strong> EBV is a major target for Antigen Mapping; managing latent viral load is essential for long-term stability.</li>
                <li><strong>Mitochondrial Support:</strong> Demyelinated axons are energy-starved; CoQ10 and ALA are critical for preventing neurodegeneration.</li>
                <li><strong>Vitamin D:</strong> High-normal levels (60-80 ng/mL) are required to shift the Th17/Treg balance toward immune tolerance.</li>
                <li><strong>Remyelination:</strong> Supporting OPC maturation through nutrients like Biotin and Quercetin is the next frontier in MS recovery.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>Bittel et al. (2022). "Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis." <i>Science</i>.</p>
            <p>Spain et al. (2017). "Lipoic acid in secondary progressive multiple sclerosis: a randomised controlled pilot trial." <i>The Lancet Neurology</i>.</p>
            <p>Lanz et al. (2022). "Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM." <i>Nature</i>.</p>
            <p>Sintzel et al. (2018). "Vitamin D and Multiple Sclerosis: A Comprehensive Review." <i>Neurology and Therapy</i>.</p>
            <p>Camara-Lemarroy et al. (2018). "The gut-brain axis in multiple sclerosis: The role of the microbiome and enteric nervous system." <i>CNS & Neurological Disorders</i>.</p>
            <p>Trapp et al. (2014). "Mitochondrial dynamics and oxidative stress in multiple sclerosis." <i>Nature Reviews Neurology</i>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>